Search

Your search keyword '"De Los Santos, I"' showing total 140 results

Search Constraints

Start Over You searched for: Author "De Los Santos, I" Remove constraint Author: "De Los Santos, I"
140 results on '"De Los Santos, I"'

Search Results

5. Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells

12. Modification of perovskite/HTL interface with cooperative polymers bilayer (PTB7-Th/P3HT) to improve perovskite solar cell efficiency and stability

14. Endometriosis umbilical secundaria: Presentación de dos casos y revisión bibliográfica

15. Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

16. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

17. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

18. TAILORED DC INDUCE PROTECTIVE HIV-1 SPECIFIC POLYFUNCTIONAL CD8+ T CELLS IN THE LYMPHOID TISSUE FROM HUMANIZED BLT MICE

19. A proposal to enhance SnS solar cell efficiency: the incorporation of SnSSe nanostructures

21. A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure

22. Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues

23. SnSe Solar Cells: Current Results and Perspectives

24. Impact of PC71BM layer on the performance of perovskite solar cells prepared at high moisture conditions using a low temperature annealed ZnO thin film as the electron transport layer

26. Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

27. Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain

28. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

29. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015

30. Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

31. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

32. Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates

33. Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

34. Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

35. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

37. Impact of a training project for primary health-care providers (FOCO project) in the HIV screening and HIV late diagnosis

38. The effect of Se/(S+Se) compositional ratios on the performance of SnS-based solar cell: a numerical simulation.

40. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

41. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study

42. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study

43. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

44. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

45. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

46. Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study

47. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

48. SAT-226 - Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study

Catalog

Books, media, physical & digital resources